Tetra-specific, octameric binding agents and antibodies against Clostridium difficile toxin A and toxin B for treatment of C. difficile infection
US-10961299-B2 · Mar 30, 2021 · US
This page is not indexed by search engines while we improve data quality.
Guan Yongjun patents
Guan Yongjun holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 0 |
| First publication | Oct 22, 2015 |
| Latest publication | Mar 30, 2021 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Tetra-specific, octameric binding agents and antibodies against clostridium difficile toxin a and toxin b for treatment of c. difficile infection
US-2018244760-A1 · Aug 30, 2018 · US
Recombinant fusion protein comprising HIV gp120 linked to an enhancing CD4 binding site mAb
US-9951106-B2 · Apr 24, 2018 · US
Hiv-1 env-binding antibodies, fusion proteins, and methods of use
US-2015299268-A1 · Oct 22, 2015 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Tetra-specific, octameric binding agents and antibodies against Clostridium difficile toxin A and toxin B for treatment of C. difficile infection
US-10961299-B2 · Mar 30, 2021 · US
Tetra-specific, octameric binding agents and antibodies against clostridium difficile toxin a and toxin b for treatment of c. difficile infection
US-2018244760-A1 · Aug 30, 2018 · US
Recombinant fusion protein comprising HIV gp120 linked to an enhancing CD4 binding site mAb
US-9951106-B2 · Apr 24, 2018 · US
Hiv-1 env-binding antibodies, fusion proteins, and methods of use
US-2015299268-A1 · Oct 22, 2015 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 4 |